At least two experimental COVID-19 vaccines produced a T-cell response in participants in early-stage clinical trials, which may indicate a longer-lasting form of immunity than an antibody response. BioNTech BNTX, + 3.46% and Pfizer Inc. PFE, + 0.69% It said early Monday morning that an ongoing early-stage clinical trial for …
Read More »AstraZeneca climbs as GlaxoSmithKline relaxes as the FTSE 100 glides
Prince William, Duke of Cambridge, wears a face mask as a precaution against the spread of COVID-19 and speaks to a patient participating in a COVID-19 vaccine trial at the Oxford Vaccine Group facility in Oxford, England, June 24, 2020. Steve Parsons / Agence France-Presse / Getty Images AstraZeneca and …
Read More »UK signs agreements with BioNTech, Pfizer and Valneva for COVID-19 vaccines
The UK government said on Monday it has secured early access to 90 million doses of vaccines from two potential COVID-19 vaccines developed by a partnership between Germany’s BioNTech and US drug maker Pfizer, as well as one by the group. French Valneva. The business ministry said it had signed …
Read More »Risks are mounting for US stocks. This is where investors should look, says BlackRock.
It is set to be a moderate start to a great earnings week. US stock futures were down at the start of a week, which will see a number of report results from big names, including Tesla TSLA, + 0.01%, Microsoft MSFT, -0.51% and United Airlines UAL, -1.65%. The race …
Read More »Vaccine Hopes Boost Earnings for European Stocks and US Stock Futures
Tourists stroll through the center of Rovinj on the Istrian peninsula in the Adriatic Sea on July 4, 2020. Denis Lovrovic / Agence France-Presse / Getty Images European stocks rose Wednesday, and US equity futures also rose as investors accepted positive news about a candidate for the coronavirus vaccine. The …
Read More »